Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Glatiramer Market Growth 2022-2028

  • LP 4891153
  • 91 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Glatiramer will have significant change from previous year. According to our (LP Information) latest study, the global Glatiramer market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Glatiramer market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Glatiramer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Glatiramer market, reaching US$ million by the year 2028. As for the Europe Glatiramer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Glatiramer players cover Teva, NATCO Pharma, Mylan, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Glatiramer market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Brand Medicine

Generic Drug

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Pharmacy

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Teva

NATCO Pharma

Mylan

Novartis

HYBIO

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Glatiramer Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Glatiramer by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Glatiramer by Country/Region, 2017, 2022 & 2028

2.2 Glatiramer Segment by Type

2.2.1 Brand Medicine

2.2.2 Generic Drug

2.3 Glatiramer Sales by Type

2.3.1 Global Glatiramer Sales Market Share by Type (2017-2022)

2.3.2 Global Glatiramer Revenue and Market Share by Type (2017-2022)

2.3.3 Global Glatiramer Sale Price by Type (2017-2022)

2.4 Glatiramer Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Other

2.5 Glatiramer Sales by Application

2.5.1 Global Glatiramer Sale Market Share by Application (2017-2022)

2.5.2 Global Glatiramer Revenue and Market Share by Application (2017-2022)

2.5.3 Global Glatiramer Sale Price by Application (2017-2022)

3 Global Glatiramer by Company

3.1 Global Glatiramer Breakdown Data by Company

3.1.1 Global Glatiramer Annual Sales by Company (2020-2022)

3.1.2 Global Glatiramer Sales Market Share by Company (2020-2022)

3.2 Global Glatiramer Annual Revenue by Company (2020-2022)

3.2.1 Global Glatiramer Revenue by Company (2020-2022)

3.2.2 Global Glatiramer Revenue Market Share by Company (2020-2022)

3.3 Global Glatiramer Sale Price by Company

3.4 Key Manufacturers Glatiramer Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Glatiramer Product Location Distribution

3.4.2 Players Glatiramer Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Glatiramer by Geographic Region

4.1 World Historic Glatiramer Market Size by Geographic Region (2017-2022)

4.1.1 Global Glatiramer Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Glatiramer Annual Revenue by Geographic Region

4.2 World Historic Glatiramer Market Size by Country/Region (2017-2022)

4.2.1 Global Glatiramer Annual Sales by Country/Region (2017-2022)

4.2.2 Global Glatiramer Annual Revenue by Country/Region

4.3 Americas Glatiramer Sales Growth

4.4 APAC Glatiramer Sales Growth

4.5 Europe Glatiramer Sales Growth

4.6 Middle East & Africa Glatiramer Sales Growth

5 Americas

5.1 Americas Glatiramer Sales by Country

5.1.1 Americas Glatiramer Sales by Country (2017-2022)

5.1.2 Americas Glatiramer Revenue by Country (2017-2022)

5.2 Americas Glatiramer Sales by Type

5.3 Americas Glatiramer Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Glatiramer Sales by Region

6.1.1 APAC Glatiramer Sales by Region (2017-2022)

6.1.2 APAC Glatiramer Revenue by Region (2017-2022)

6.2 APAC Glatiramer Sales by Type

6.3 APAC Glatiramer Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Glatiramer by Country

7.1.1 Europe Glatiramer Sales by Country (2017-2022)

7.1.2 Europe Glatiramer Revenue by Country (2017-2022)

7.2 Europe Glatiramer Sales by Type

7.3 Europe Glatiramer Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Glatiramer by Country

8.1.1 Middle East & Africa Glatiramer Sales by Country (2017-2022)

8.1.2 Middle East & Africa Glatiramer Revenue by Country (2017-2022)

8.2 Middle East & Africa Glatiramer Sales by Type

8.3 Middle East & Africa Glatiramer Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Glatiramer

10.3 Manufacturing Process Analysis of Glatiramer

10.4 Industry Chain Structure of Glatiramer

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Glatiramer Distributors

11.3 Glatiramer Customer

12 World Forecast Review for Glatiramer by Geographic Region

12.1 Global Glatiramer Market Size Forecast by Region

12.1.1 Global Glatiramer Forecast by Region (2023-2028)

12.1.2 Global Glatiramer Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Glatiramer Forecast by Type

12.7 Global Glatiramer Forecast by Application

13 Key Players Analysis

13.1 Teva

13.1.1 Teva Company Information

13.1.2 Teva Glatiramer Product Offered

13.1.3 Teva Glatiramer Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Teva Main Business Overview

13.1.5 Teva Latest Developments

13.2 NATCO Pharma

13.2.1 NATCO Pharma Company Information

13.2.2 NATCO Pharma Glatiramer Product Offered

13.2.3 NATCO Pharma Glatiramer Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 NATCO Pharma Main Business Overview

13.2.5 NATCO Pharma Latest Developments

13.3 Mylan

13.3.1 Mylan Company Information

13.3.2 Mylan Glatiramer Product Offered

13.3.3 Mylan Glatiramer Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mylan Main Business Overview

13.3.5 Mylan Latest Developments

13.4 Novartis

13.4.1 Novartis Company Information

13.4.2 Novartis Glatiramer Product Offered

13.4.3 Novartis Glatiramer Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis Main Business Overview

13.4.5 Novartis Latest Developments

13.5 HYBIO

13.5.1 HYBIO Company Information

13.5.2 HYBIO Glatiramer Product Offered

13.5.3 HYBIO Glatiramer Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 HYBIO Main Business Overview

13.5.5 HYBIO Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Glatiramer Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Glatiramer Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Brand Medicine

Table 4. Major Players of Generic Drug

Table 5. Global Glatiramer Sales by Type (2017-2022) & (K Units)

Table 6. Global Glatiramer Sales Market Share by Type (2017-2022)

Table 7. Global Glatiramer Revenue by Type (2017-2022) & ($ million)

Table 8. Global Glatiramer Revenue Market Share by Type (2017-2022)

Table 9. Global Glatiramer Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Glatiramer Sales by Application (2017-2022) & (K Units)

Table 11. Global Glatiramer Sales Market Share by Application (2017-2022)

Table 12. Global Glatiramer Revenue by Application (2017-2022)

Table 13. Global Glatiramer Revenue Market Share by Application (2017-2022)

Table 14. Global Glatiramer Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Glatiramer Sales by Company (2020-2022) & (K Units)

Table 16. Global Glatiramer Sales Market Share by Company (2020-2022)

Table 17. Global Glatiramer Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Glatiramer Revenue Market Share by Company (2020-2022)

Table 19. Global Glatiramer Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Glatiramer Producing Area Distribution and Sales Area

Table 21. Players Glatiramer Products Offered

Table 22. Glatiramer Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Glatiramer Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Glatiramer Sales Market Share Geographic Region (2017-2022)

Table 27. Global Glatiramer Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Glatiramer Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Glatiramer Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Glatiramer Sales Market Share by Country/Region (2017-2022)

Table 31. Global Glatiramer Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Glatiramer Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Glatiramer Sales by Country (2017-2022) & (K Units)

Table 34. Americas Glatiramer Sales Market Share by Country (2017-2022)

Table 35. Americas Glatiramer Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Glatiramer Revenue Market Share by Country (2017-2022)

Table 37. Americas Glatiramer Sales by Type (2017-2022) & (K Units)

Table 38. Americas Glatiramer Sales Market Share by Type (2017-2022)

Table 39. Americas Glatiramer Sales by Application (2017-2022) & (K Units)

Table 40. Americas Glatiramer Sales Market Share by Application (2017-2022)

Table 41. APAC Glatiramer Sales by Region (2017-2022) & (K Units)

Table 42. APAC Glatiramer Sales Market Share by Region (2017-2022)

Table 43. APAC Glatiramer Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Glatiramer Revenue Market Share by Region (2017-2022)

Table 45. APAC Glatiramer Sales by Type (2017-2022) & (K Units)

Table 46. APAC Glatiramer Sales Market Share by Type (2017-2022)

Table 47. APAC Glatiramer Sales by Application (2017-2022) & (K Units)

Table 48. APAC Glatiramer Sales Market Share by Application (2017-2022)

Table 49. Europe Glatiramer Sales by Country (2017-2022) & (K Units)

Table 50. Europe Glatiramer Sales Market Share by Country (2017-2022)

Table 51. Europe Glatiramer Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Glatiramer Revenue Market Share by Country (2017-2022)

Table 53. Europe Glatiramer Sales by Type (2017-2022) & (K Units)

Table 54. Europe Glatiramer Sales Market Share by Type (2017-2022)

Table 55. Europe Glatiramer Sales by Application (2017-2022) & (K Units)

Table 56. Europe Glatiramer Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Glatiramer Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Glatiramer Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Glatiramer Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Glatiramer Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Glatiramer Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Glatiramer Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Glatiramer Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Glatiramer Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Glatiramer

Table 66. Key Market Challenges & Risks of Glatiramer

Table 67. Key Industry Trends of Glatiramer

Table 68. Glatiramer Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Glatiramer Distributors List

Table 71. Glatiramer Customer List

Table 72. Global Glatiramer Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Glatiramer Sales Market Forecast by Region

Table 74. Global Glatiramer Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Glatiramer Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Glatiramer Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Glatiramer Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Glatiramer Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Glatiramer Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Glatiramer Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Glatiramer Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Glatiramer Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Glatiramer Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Glatiramer Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Glatiramer Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Glatiramer Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Glatiramer Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Glatiramer Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Glatiramer Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Glatiramer Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Glatiramer Revenue Market Share Forecast by Application (2023-2028)

Table 92. Teva Basic Information, Glatiramer Manufacturing Base, Sales Area and Its Competitors

Table 93. Teva Glatiramer Product Offered

Table 94. Teva Glatiramer Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Teva Main Business

Table 96. Teva Latest Developments

Table 97. NATCO Pharma Basic Information, Glatiramer Manufacturing Base, Sales Area and Its Competitors

Table 98. NATCO Pharma Glatiramer Product Offered

Table 99. NATCO Pharma Glatiramer Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. NATCO Pharma Main Business

Table 101. NATCO Pharma Latest Developments

Table 102. Mylan Basic Information, Glatiramer Manufacturing Base, Sales Area and Its Competitors

Table 103. Mylan Glatiramer Product Offered

Table 104. Mylan Glatiramer Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Mylan Main Business

Table 106. Mylan Latest Developments

Table 107. Novartis Basic Information, Glatiramer Manufacturing Base, Sales Area and Its Competitors

Table 108. Novartis Glatiramer Product Offered

Table 109. Novartis Glatiramer Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Novartis Main Business

Table 111. Novartis Latest Developments

Table 112. HYBIO Basic Information, Glatiramer Manufacturing Base, Sales Area and Its Competitors

Table 113. HYBIO Glatiramer Product Offered

Table 114. HYBIO Glatiramer Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. HYBIO Main Business

Table 116. HYBIO Latest Developments

List of Figures

Figure 1. Picture of Glatiramer

Figure 2. Glatiramer Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Glatiramer Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Glatiramer Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Glatiramer Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Brand Medicine

Figure 10. Product Picture of Generic Drug

Figure 11. Global Glatiramer Sales Market Share by Type in 2021

Figure 12. Global Glatiramer Revenue Market Share by Type (2017-2022)

Figure 13. Glatiramer Consumed in Hospital

Figure 14. Global Glatiramer Market: Hospital (2017-2022) & (K Units)

Figure 15. Glatiramer Consumed in Pharmacy

Figure 16. Global Glatiramer Market: Pharmacy (2017-2022) & (K Units)

Figure 17. Glatiramer Consumed in Other

Figure 18. Global Glatiramer Market: Other (2017-2022) & (K Units)

Figure 19. Global Glatiramer Sales Market Share by Application (2017-2022)

Figure 20. Global Glatiramer Revenue Market Share by Application in 2021

Figure 21. Glatiramer Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Glatiramer Revenue Market Share by Company in 2021

Figure 23. Global Glatiramer Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Glatiramer Revenue Market Share by Geographic Region in 2021

Figure 25. Global Glatiramer Sales Market Share by Region (2017-2022)

Figure 26. Global Glatiramer Revenue Market Share by Country/Region in 2021

Figure 27. Americas Glatiramer Sales 2017-2022 (K Units)

Figure 28. Americas Glatiramer Revenue 2017-2022 ($ Millions)

Figure 29. APAC Glatiramer Sales 2017-2022 (K Units)

Figure 30. APAC Glatiramer Revenue 2017-2022 ($ Millions)

Figure 31. Europe Glatiramer Sales 2017-2022 (K Units)

Figure 32. Europe Glatiramer Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Glatiramer Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Glatiramer Revenue 2017-2022 ($ Millions)

Figure 35. Americas Glatiramer Sales Market Share by Country in 2021

Figure 36. Americas Glatiramer Revenue Market Share by Country in 2021

Figure 37. United States Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Glatiramer Sales Market Share by Region in 2021

Figure 42. APAC Glatiramer Revenue Market Share by Regions in 2021

Figure 43. China Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Glatiramer Sales Market Share by Country in 2021

Figure 50. Europe Glatiramer Revenue Market Share by Country in 2021

Figure 51. Germany Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Glatiramer Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Glatiramer Revenue Market Share by Country in 2021

Figure 58. Egypt Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Glatiramer Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Glatiramer in 2021

Figure 64. Manufacturing Process Analysis of Glatiramer

Figure 65. Industry Chain Structure of Glatiramer

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390